BamSEC and AlphaSense Join Forces
Learn More

Ocular Therapeutix Inc. – Material Contracts

NASDAQ: OCUL    
Share price (11/18/26): $5.94    
Market cap (11/18/26): $1.307 billion

Material Contracts Filter

EX-10.3
from 10-Q 4 pages November 7, 2026 Nadia Waheed Chief Medical Officer Ocular Therapeutix, Inc. 14 Crosby Drive, 3rd Floor Bedford, Massachusetts 01730 Dear Nadia
12/34/56
EX-10.2
from 10-Q 5 pages First Amendment to Sublease Agreement
12/34/56
EX-10.1
from 10-Q 1 page Amendment No. 6 to 2019 Inducement Stock Incentive Plan ​
12/34/56
EX-10.3
from 10-Q 30 pages Triple Net Office Lease Reference Pages
12/34/56
EX-10.1
from 10-Q 10 pages Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as Amended
12/34/56
EX-10.4
from 10-Q 24 pages Employment Agreement
12/34/56
EX-10.3
from 10-Q 37 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 86 pages This Sublease Agreement (“Sublease”) Is Made as of January 1, 2026 (The “Sublease Date”), by and Between Quanterix Corporation, a Delaware Corporation (“Sublandlord”), and Ocular Therapeutix, Inc., a Delaware Corporation (“Subtenant”)
12/34/56
EX-10.5
from 10-Q 37 pages Employment Agreement
12/34/56
EX-10.4
from 10-Q 2 pages Amendment #1 to Employment Agreement
12/34/56
EX-10.3
from 10-Q 32 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 5 pages Ocular Therapeutix, Inc. Amended and Restated 2014 Employee Stock Purchase Plan
12/34/56
EX-10.1
from 10-Q 11 pages Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as Amended
12/34/56
EX-10.5
from 10-Q 9 pages Ocular Therapeutix, Inc. Performance Stock Option Agreement
12/34/56
EX-10.4
from 10-Q 10 pages Ocular Therapeutix, Inc. Performance Stock Unit Agreement
12/34/56
EX-10.3
from 10-Q 9 pages Ocular Therapeutix, Inc. Restricted Stock Unit Agreement
12/34/56
EX-10.52
from 10-K 7 pages ​ Ocular Therapeutix, Inc. 15 Crosby Drive Bedford, Ma 01730 ​ March 1, 2025 ​
12/34/56
EX-10.49
from 10-K 7 pages ​ Ocular Therapeutix, Inc. 15 Crosby Drive Bedford, Ma 01730 ​ March 1, 2025 ​
12/34/56
EX-10.4
from 10-Q 18 pages ​ Employment Agreement
12/34/56
EX-10.3
from 10-Q 2 pages Peter K. Kaiser, MD Ocular Therapeutix, Inc. Medical Director Dear Peter: Section 1(b) of the Employment Agreement Dated as of February 21, 2024 (The “Employment Agreement”) Between You and Ocular Therapeutix, Inc. (The “Company”) Provides That You Will Be Employed by the Company to Serve on a Part-Time Basis, Working 50% of a Full- Time Schedule
12/34/56